John Overdeck’s Sabra Healthcare REIT SBRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $38M | Sell |
1,947,826
-560,536
| -22% | -$11.1M | 0.03% | 687 |
|
|
2026
Q1 | $48.2M | Buy |
2,508,362
+2,330,279
| +1,309% | +$45.9M | 0.04% | 516 |
|
|
2025
Q4 | $3.37M | Buy |
178,083
+94,956
| +114% | +$1.76M | ﹤0.01% | 2054 |
|
|
2025
Q3 | $1.55M | Buy |
+83,127
| New | +$1.55M | ﹤0.01% | 2299 |
|
|
2024
Q4 | – | Sell |
-20,949
| Closed | -$390K | – | 3440 |
|
|
2024
Q3 | $390K | Buy |
20,949
+619
| +3% | +$10.4K | ﹤0.01% | 2572 |
|
|
2024
Q2 | $313K | Buy |
+20,330
| New | +$290K | ﹤0.01% | 2576 |
|
|
2022
Q3 | – | Sell |
-53,430
| Closed | -$746K | – | 2780 |
|
|
2022
Q2 | $746K | Buy |
53,430
+16,700
| +45% | +$223K | ﹤0.01% | 1668 |
|
|
2022
Q1 | $547K | Buy |
+36,730
| New | +$503K | ﹤0.01% | 1977 |
|
|
2021
Q3 | – | Sell |
-106,907
| Closed | -$1.95M | – | 4638 |
|
|
2021
Q2 | $1.95M | Buy |
106,907
+55,618
| +108% | +$990K | ﹤0.01% | 1888 |
|
|
2021
Q1 | $890K | Sell |
51,289
-5,471
| -10% | -$96.2K | ﹤0.01% | 2424 |
|
|
2020
Q4 | $986K | Buy |
+56,760
| New | +$906K | ﹤0.01% | 2024 |
|
|
2020
Q1 | – | Sell |
-663,411
| Closed | -$14.2M | – | 3741 |
|
|
2019
Q4 | $14.2M | Buy |
663,411
+213,901
| +48% | +$4.79M | 0.04% | 487 |
|
|
2019
Q3 | $10.3M | Buy |
449,510
+317,990
| +242% | +$6.78M | 0.03% | 534 |
|
|
2019
Q2 | $2.59M | Buy |
+131,520
| New | +$2.56M | 0.01% | 1270 |
|
|
2019
Q1 | – | Sell |
-404,794
| Closed | -$6.67M | – | 3418 |
|
|
2018
Q4 | $6.67M | Sell |
404,794
-95,153
| -19% | -$1.92M | 0.03% | 673 |
|
|
2018
Q3 | $11.6M | Buy |
499,947
+125,136
| +33% | +$2.84M | 0.03% | 597 |
|
|
2018
Q2 | $8.14M | Buy |
374,811
+244,279
| +187% | +$4.77M | 0.02% | 756 |
|
|
2018
Q1 | $2.3M | Sell |
130,532
-118,170
| -48% | -$2.08M | 0.01% | 1428 |
|
|
2017
Q4 | $4.67M | Sell |
248,702
-342,499
| -58% | -$6.81M | 0.02% | 939 |
|
|
2017
Q3 | $13M | Sell |
591,201
-404,615
| -41% | -$9.14M | 0.05% | 435 |
|
|
2017
Q2 | $24M | Buy |
995,816
+976,358
| +5,018% | +$24.8M | 0.09% | 283 |
|
|
2017
Q1 | $543K | Sell |
19,458
-54,134
| -74% | -$1.42M | ﹤0.01% | 2293 |
|
|
2016
Q4 | $1.8M | Sell |
73,592
-305,186
| -81% | -$7M | 0.01% | 1573 |
|
|
2016
Q3 | $9.54M | Sell |
378,778
-11,434
| -3% | -$274K | 0.03% | 565 |
|
|
2016
Q2 | $8.05M | Buy |
390,212
+212,700
| +120% | +$4.43M | 0.03% | 555 |
|
|
2016
Q1 | $3.57M | Buy |
177,512
+146,546
| +473% | +$2.81M | 0.02% | 865 |
|
|
2015
Q4 | $626K | Buy |
+30,966
| New | +$652K | ﹤0.01% | 1828 |
|
|
2015
Q2 | – | Sell |
-50,620
| Closed | -$1.68M | – | 3058 |
|
|
2015
Q1 | $1.68M | Sell |
50,620
-182,711
| -78% | -$5.93M | 0.01% | 1270 |
|
|
2014
Q4 | $7.09M | Buy |
233,331
+146,213
| +168% | +$4.03M | 0.04% | 534 |
|
|
2014
Q3 | $2.12M | Buy |
+87,118
| New | +$2.42M | 0.01% | 851 |
|
|
2014
Q1 | – | Sell |
-64,227
| Closed | -$1.68M | – | 2216 |
|
|
2013
Q4 | $1.68M | Buy |
+64,227
| New | +$1.66M | 0.01% | 1085 |
|
|
2013
Q3 | – | Sell |
-103,804
| Closed | -$2.71M | – | 2073 |
|
|
2013
Q2 | $2.71M | Buy |
+103,804
| New | +$3M | 0.02% | 757 |
|
Other funds holding SBRA
CIM
John Overdeck's SBRA Position: Q2 2026 in Review
John Overdeck reduced its Sabra Healthcare REIT (SBRA) stake by 22% in Q2 2026, selling an estimated $11.1M and leaving 1,947,826 shares worth $38M. The position accounts for 0.03% of the portfolio, ranked #687.
John Overdeck first reported a position in SBRA in Q2 2013 and has held it in 32 quarters since. The position peaked at $48.2M in Q1 2026. 461 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.
- John Overdeck held 1,947,826 shares of Sabra Healthcare REIT worth $38M as of Q2 2026.
- John Overdeck sold 560,536 Sabra Healthcare REIT shares in Q2 2026, an estimated $11.1M.
- Sabra Healthcare REIT made up 0.03% of John Overdeck's portfolio in Q2 2026, its #687 holding.
- John Overdeck first reported a position in Sabra Healthcare REIT in Q2 2013 and has held it in 32 quarters since.
- John Overdeck's Sabra Healthcare REIT position peaked at $48.2M in Q1 2026.
- 461 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.
Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.